Nuclear capital portfolios are often destabilized by poor discovery, vague problem statements, and weak project valuations, leading to emergent work and cost overruns. This white paper outlines MCR’s proven, risk‑based approach to valuing and prioritizing capital projects, enabling executives to rank projects objectively and allocate limited capital without compromising safety or reliability.